Period ? The period in which lectures are held 1: 30/09/2024 - 23/01/2025 2: 26/02/2025 - 13/06/2025 4: 30/09/2024 - 30/01/2025 A: 16/09/2024 - 17/12/2024 E: 30/09/2024 - 13/06/2025 | ssd ? Disciplinary-scientific area to which the learning activity belongs | cfu ? Credits | ||
---|---|---|---|---|
85284 | Bioethics | 1 | 3 | |
90916 | Elements of Animal Biology, Elements of Genetics (I.C.) | 1 | ||
90917 Elements of Animal Biology | 1 | BIO/05 | 3 | |
90918 Elements of Genetics | 1 | BIO/18 | 3 | |
99738 |
Physics, Elements of Mathematics (I.C.)
Access to the learning activity Physics is subject to obtaining the signature attesting the attendance at Elements of Mathematics |
1 | ||
99739 Elements of Mathematics | 1 | MAT/05 | 5 | |
99477 Physics | 2 | FIS/01 | 7 | |
90928 | Acquisition of Computer Skills and Biostatistics | 2 | 4 | |
90931 | General and Inorganic Chemistry | E | CHIM/03 | 10 |
76148 | Human Anatomy | E | BIO/16 | 7 |
90919 | Plant Biology, Pharmaceutical Botany | E | BIO/15 | 9 |
Period ? The period in which lectures are held 1: 30/09/2024 - 23/01/2025 2: 26/02/2025 - 13/06/2025 4: 30/09/2024 - 30/01/2025 A: 16/09/2024 - 17/12/2024 E: 30/09/2024 - 13/06/2025 | ssd ? Disciplinary-scientific area to which the learning activity belongs | cfu ? Credits | ||
---|---|---|---|---|
90954 | Basic Life Support and Life Styles | 2 | BIO/16 | 4 |
92625 | Introduction and Perspectives of Pharmacy Course | 2 | 4 |
Period ? The period in which lectures are held 1: 30/09/2024 - 23/01/2025 2: 26/02/2025 - 13/06/2025 4: 30/09/2024 - 30/01/2025 A: 16/09/2024 - 17/12/2024 E: 30/09/2024 - 13/06/2025 | ssd ? Disciplinary-scientific area to which the learning activity belongs | cfu ? Credits | ||
---|---|---|---|---|
96177 |
Analytical Chemistry
Prerequisite: General and Inorganic Chemistry |
1 | CHIM/01 | 6 |
91007 |
Microbiology and Public Health, Elements of Epidemiology (I.C.)
Prerequisite for Microbiology and Public Health: Elements of Animal Biology. Prerequisite for Elements of Epidemiology: Microbiology and Public Health. |
1 | ||
91009 Elements of Epidemiology | 1 | MED/42 | 3 | |
91008 Microbiology and Public Health | 1 | MED/07 | 9 | |
90967 |
Organic Chemistry
Prerequisite: General and Inorganic Chemistry |
1 | CHIM/06 | 10 |
90965 |
Drug Analysis I
Access to the learning activity (lectures and practical work) is subject to passing the exam of General and Inorganic Chemistry. Prerequisite: Analytical Chemistry |
2 | CHIM/08 | 8 |
90968 |
General and Molecular Biochemistry
Prerequisite: Elements of Animal Biology and Organic Chemistry |
2 | BIO/10 | 10 |
91011 |
Human Physiology
Prerequisite: Physics, General and Molecular Biochemistry and Human Anatomy |
2 | BIO/09 | 10 |
Period ? The period in which lectures are held 1: 30/09/2024 - 23/01/2025 2: 26/02/2025 - 13/06/2025 4: 30/09/2024 - 30/01/2025 A: 16/09/2024 - 17/12/2024 E: 30/09/2024 - 13/06/2025 | ssd ? Disciplinary-scientific area to which the learning activity belongs | cfu ? Credits | ||
---|---|---|---|---|
91012 |
Applied Medical Biochemistry
Prerequisite: General and Molecular Biochemistry |
1 | BIO/10 | 6 |
91022 |
Drug Analysis II
Access to the learning activity (lectures and practical work) is subject to passing the exam of Organic Chemistry and obtaining the signature attesting the attendance at Drug Analysis I. Prerequisite: Physics, Elements of Mathematics (I.C.), Drug Analysis I and Organic Chemistry |
1 | CHIM/08 | 8 |
91023 |
Molecular and Clinical Pathology (I.C.)
Prerequisite: Human Physiology and Microbiology and Public Health, Elements of Epidemiology (I.C.) |
1 | ||
91024 Basis of Clinical Molecular Biology | 1 | BIO/12 | 3 | |
84357 General Pathology | 1 | MED/04 | 7 | |
91013 |
Nutritional Physiology, Nutritional Biochemistry and Nutraceutics (I.C.)
Prerequisite: General and Molecular Biochemistry and Human Physiology |
1 | ||
91015 Nutritional Biochemistry and Nutraceutics | 1 | BIO/10 | 4 | |
91014 Nutritional Physiology | 2 | BIO/09 | 3 | |
B3254 |
Advanced Analysis of Health Products
Access to the learning activity (lectures and practical work) is subject to passing the exam of Organic Chemistry and obtaining the signature attesting the attendance at Drug Analysis I and II. |
2 | CHIM/08 | 6 |
91025 |
Medicinal and Toxicological Chemistry I
Prerequisite: General and Molecular Biochemistry |
2 | CHIM/08 | 9 |
91017 |
Pharmacognosy and Phytotherapy
Prerequisite: Plant Biology, Pharmaceutical Botany and Human Physiology |
2 | BIO/14 | 6 |
91026 |
General Pharmacology, Pharmacogenetics and Pharmacotherapy I
Prerequisite: Human Physiology and Microbiology and Public Health, Elements of Epidemiology (I.C.) |
E | BIO/14 | 8 |
Period ? The period in which lectures are held 1: 30/09/2024 - 23/01/2025 2: 26/02/2025 - 13/06/2025 4: 30/09/2024 - 30/01/2025 A: 16/09/2024 - 17/12/2024 E: 30/09/2024 - 13/06/2025 | ssd ? Disciplinary-scientific area to which the learning activity belongs | cfu ? Credits | ||
---|---|---|---|---|
91039 |
Medicinal and Toxicological Chemistry II
Prerequisite: Medicinal and Toxicological Chemistry I. |
1 | CHIM/08 | 9 |
91040 |
Molecular Basis of Biotechnological Drugs (I.C.)
Prerequisite for Medicinal Chemistry of Biotechnological Drugs: Medicinal and Toxicological Chemistry I. Prerequisite for Molecular Pharmacology and Pharmacotherapy of Biotechnological Drugs: Pharmacognosy and Phytotherapy and General Pathology. |
1 | ||
91041 Medicinal Chemistry of Biotechnological Drugs | 1 | CHIM/08 | 3 | |
91042 Molecular Pharmacology and Pharmacotherapy of Biotechnological Drugs | 2 | BIO/14 | 5 | |
B2940 |
Pharmaceutical Technology and Galenic Pharmacy
Prerequisite: Medicinal and Toxicological Chemistry I and Physics, Elements of Mathematics (I.C.) |
1 | CHIM/09 | 12 |
91044 |
Prinicples of Pharmaceutical and Clinical Care (I.C.)
Prerequisite: General Pharmacology, Pharmacogenetics and Pharmacotherapy I and Molecular and Clinical Pathology (I.C.). |
4 | ||
B2954 Digital Healthcare | 4 | ING-INF/06 | 3 | |
91045 Pharmaceutical Care | 1 | BIO/14 | 3 | |
91046 Principles of Clinical Care | 1 | MED/05 | 3 | |
91043 |
Pharmacology and Pharmacotherapy II
Prerequisite: General Pharmacology, Pharmacogenetics and Pharmacotherapy I and Molecular and Clinical Pathology (I.C.). |
E | BIO/14 | 9 |
Period ? The period in which lectures are held 1: 30/09/2024 - 23/01/2025 2: 26/02/2025 - 13/06/2025 4: 30/09/2024 - 30/01/2025 A: 16/09/2024 - 17/12/2024 E: 30/09/2024 - 13/06/2025 | ssd ? Disciplinary-scientific area to which the learning activity belongs | cfu ? Credits | ||
---|---|---|---|---|
B2956 | Circular Economy in the Pharmaceutical and Cosmetic Industry | 1 | CHIM/11 | 4 |
B3081 | Radiopharmaceuticals for Molecula Imaging and Radiology and Therapy | 1 | CHIM/03 | 4 |
36420 | Acquisition of Management and Computer Skills in Pharmacy | 2 | CHIM/09 | 4 |
94236 | Chemistry of Antioxidants | 2 | CHIM/06 | 4 |
65219 | Dermatology | 2 | MED/35 | 4 |
B2958 | Food Chemistry and Nutraceuticals | 2 | CHIM/10 | 4 |
B3162 | Metabolomics in Life Sciences | 2 | BIO/10 | 4 |
99734 | Monitoring of Pharmaceutical Drugs and Doping Agents | 2 | CHIM/08 | 4 |
99726 | Nanosciences for Pharmacy and Medicine | 2 | CHIM/03 | 4 |
B2957 | Paediatric and Geriatric Medicinal Products | 2 | CHIM/09 | 4 |
Period ? The period in which lectures are held 1: 30/09/2024 - 23/01/2025 2: 26/02/2025 - 13/06/2025 4: 30/09/2024 - 30/01/2025 A: 16/09/2024 - 17/12/2024 E: 30/09/2024 - 13/06/2025 | cfu ? Credits | |||
---|---|---|---|---|
91060 | Internship Final Dissertation | 1 | 12 | |
91059 | Internship Final Dissertation Abroad | 1 | 12 | |
91056 | Methods and Research Tools for the Compilative or Proactical-Professional Dissertation | 1 | 12 | |
91057 | Preparation Final Dissertation Abroad | 1 | 12 |
Period ? The period in which lectures are held 1: 30/09/2024 - 23/01/2025 2: 26/02/2025 - 13/06/2025 4: 30/09/2024 - 30/01/2025 A: 16/09/2024 - 17/12/2024 E: 30/09/2024 - 13/06/2025 | ssd ? Disciplinary-scientific area to which the learning activity belongs | cfu ? Credits | ||
---|---|---|---|---|
B3080 | PPV Evaluation Practical Test LM | 1 | 0 | |
81976 |
Final Examination LM
Admission to the Final Examination is subject to the acquisition of all the credits indicated in the Programme Regulations. |
2 | 3 | |
B2970 |
Advanced Drug Deliveryand Nanotechnology
Access to the learning activity is subject to obtaining the signature attesting the attendance at Pharmaceutical Technology and Galenic Pharmacy. Prerequisite: Pharmaceutical Technology and Galenic Pharmacy |
A | CHIM/09 | 8 |
91064 |
Pharmacovigilance and Pharmacoepidemiology
Prerequisite: Pharmacology and Pharmacotherapy II |
A | BIO/14 | 5 |
B2971 |
Pharmacy Law, Ethics and Regulation (I.C.)
Access to the learning activity is subject to obtaining the signature attesting the attendance at Pharmaceutical Technology and Galenic Pharmacy. Prerequisite: Pharmaceutical Technology and Galenic Pharmacy |
A | ||
B2973 Pharmacy Financial Management | A | SECS-P/07 | 3 | |
B2972 Pharmacy Law, Ethics and Regulation | A | CHIM/09 | 8 | |
91063 |
Toxicology
Prerequisite: General Pharmacology, Pharmacogenetics and Pharmacotherapy I |
A | BIO/14 | 9 |
Period ? The period in which lectures are held 1: 30/09/2024 - 23/01/2025 2: 26/02/2025 - 13/06/2025 4: 30/09/2024 - 30/01/2025 A: 16/09/2024 - 17/12/2024 E: 30/09/2024 - 13/06/2025 | cfu ? Credits | |||
---|---|---|---|---|
B3070 |
TPV Evaluation Internship LM
Access to the Internship is subject to having attended the lectures of all the learning activities of the fourth year, as well as the lectures of Toxicology, Pharmacovigilance and Pharmacoepidemiology. The minimum length of the Internship is 6 months (full-time) at a pharmacy open to the public, a hospital, under the guidance of the Pharmaceutical Service (“Servizio Farmaceutico”), to be completed in accordance with the Internships Regulations. Prerequisite: General Pharmacology, Pharmacogenetics and Pharmacotherapy I, Pharmaceutical Technology and Galenic Pharmacy and Pharmacy Law, Ethics and Regulation I.C. |
1 | 30 | |
B3839 |
TPV Evaluation Internship LM I.C.
Access to the Internship is subject to having attended the lectures of all the learning activities of the fourth year, as well as the lectures of Toxicology, Pharmacovigilance and Pharmacoepidemiology. The minimum length of the Internship is 6 months (full-time) at a pharmacy open to the public, a hospital, under the guidance of the Pharmaceutical Service (“Servizio Farmaceutico”), to be completed in accordance with the Internships Regulations. Prerequisite: General Pharmacology, Pharmacogenetics and Pharmacotherapy I, Pharmaceutical Technology and Galenic Pharmacy and Pharmacy Law, Ethics and Regulation I.C. |
1 | ||
B3840 TPV Evaluation Internship A 15 CFU | 1 | 15 | ||
B3841 TPV Evaluation Internship B 15 CFU | 1 | 15 |